In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Smith & Nephew acquires Nucryst for $28mm

Executive Summary

Smith & Nephew Advanced Wound Management has closed its acquisition of Nucryst Pharmaceuticals, a public company with wound care products and pharmaceuticals based on a nanocrystalline silver technology. S&N paid $21mm in cash plus other working capital adjustments of $7mm.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register